Skip to main content
logo
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.320
-0.080 (-2.35%)
At close: Sep 11, 2026, 4:00 PM EDT
3.500
+0.180 (5.42%)
After-hours: Sep 11, 2026, 4:10 PM EDT

X4 Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
32935012514012164
Market Cap Growth
347.04%179.54%-10.81%16.23%87.36%-38.49%
Enterprise Value
19830568577928
Last Close Price
3.404.0022.0125.1629.7968.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.339.9648.93---
PB Ratio
2.101.885.652.751.631.00
P/TBV Ratio
2.702.19-4.162.131.37

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
13.088.6826.73---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.500.423.531.140.520.62
Net Debt / Equity Ratio
-0.84-0.94-1.08-1.09-1.12-0.65
Net Debt / EBITDA Ratio
1.662.240.170.520.950.56
Net Debt / FCF Ratio
1.562.050.180.581.080.59
Asset Turnover
0.090.160.02---
Inventory Turnover
0.681.58----
Quick Ratio
10.859.853.165.025.505.89
Current Ratio
11.3010.163.415.345.766.27
Return on Equity (ROE)
-113.08%-75.99%-102.26%-161.67%-135.58%-129.28%
Return on Assets (ROA)
-28.15%-22.86%-60.18%-44.38%-40.36%-39.24%
Return on Capital Employed (ROCE)
-34.50%-30.20%-124.50%-86.40%-66.10%-73.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-26.66%-22.64%-29.93%-72.12%-77.78%-137.70%
FCF Yield
-24.77%-24.48%-104.89%-68.84%-63.97%-111.04%
Buyback Yield / Dilution
-1374.07%-531.04%-13.08%-179.91%-146.71%-28.25%
SEC Filings: 10-K · 10-Q